# Syndax Pharmaceuticals Inc: Form 8-K, filed Aug 4, 2025

- Company: [Syndax Pharmaceuticals Inc](/companies/sndx.md) (CIK 1395937)
- Form: 8-K
- Filed: 2025-08-04
- Accepted by EDGAR: Aug 4, 2025, 16:02 ET
- Period: 2025-08-04
- Accession: 0000950170-25-101974
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1395937/000095017025101974/sndx-20250804.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395937/000095017025101974/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395937/000095017025101974/sndx-20250804.htm

Filed Aug 4, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-101974. Last ingested by Listed: Oct 30, 2026, 19:11 ET. No prices; not investment advice.